Published in Clin Exp Immunol on April 01, 1999
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res (2008) 1.40
High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology (2006) 1.09
Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis (2010) 1.09
Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med (2009) 1.03
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses (2013) 0.99
The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J (2012) 0.91
HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol (2013) 0.89
Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer (2013) 0.89
Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study. Infect Dis Obstet Gynecol (2002) 0.88
The paradox of IL-10-mediated modulation in cervical cancer. Biomed Rep (2013) 0.85
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog (2003) 0.85
HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC. Epigenetics (2014) 0.84
Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128. Clin Cancer Res (2009) 0.82
Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China. Int J Clin Exp Pathol (2014) 0.80
The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infect Agent Cancer (2009) 0.80
Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology (2015) 0.79
Immunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinoma. J Appl Oral Sci (2011) 0.79
Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil. J Clin Microbiol (2005) 0.78
Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota. Mucosal Immunol (2017) 0.77
Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma. Clin Vaccine Immunol (2009) 0.77
Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol (2015) 0.77
A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Gynecol Oncol (2015) 0.77
Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women. Indian J Med Res (2014) 0.75
Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer. Int J Mol Sci (2017) 0.75
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 11.04
Human papillomaviruses in the pathogenesis of anogenital cancer. Virology (1991) 5.74
IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol (1992) 2.89
The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988. Acta Cytol (1989) 2.25
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol (1993) 2.20
Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest (1993) 2.16
Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis (1996) 2.12
Natural history of HLA expression during tumour development. Immunol Today (1993) 2.04
Identification and induction of keratinocyte-derived IL-10. J Immunol (1992) 1.87
Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology (1995) 1.86
Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol (1992) 1.58
Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci U S A (1991) 1.47
Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol (1990) 1.43
Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J Immunol (1993) 1.42
Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer (1994) 1.27
Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol (1987) 1.19
Maturation and migration of cutaneous dendritic cells. J Invest Dermatol (1995) 1.13
Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro. J Clin Invest (1989) 1.11
Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis. Arch Dermatol Res (1992) 0.98
Phenotypic changes in Langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? J Virol (1996) 0.98
Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation. J Immunol (1994) 0.95
Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. J Invest Dermatol (1986) 0.93
Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin Immunol Immunopathol (1994) 0.93
Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. Int J Cancer (1994) 0.91
Regulation of cathepsin E expression during human B cell differentiation in vitro. Eur J Immunol (1996) 0.84
Local immune response in persistent cervical dysplasia. Obstet Gynecol (1993) 0.83
The ICAM-3/LFA-1 interaction is critical for epidermal Langerhans cell alloantigen presentation to CD4+ T cells. Br J Dermatol (1995) 0.83
Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM1) expression in human papillomavirus (HPV)-induced lesions. J Pathol (1992) 0.82
Differential regulation of HLA-DQ expression by keratinocytes and Langerhans cells in normal and premalignant cervical epithelium. Tissue Antigens (1998) 0.79
Vertebrate genome evolution and the zebrafish gene map. Nat Genet (1998) 5.16
Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J Clin Microbiol (2007) 4.55
Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet (1986) 4.55
New estimates of undocumented Mexican migration and the probability of apprehension. Demography (1995) 3.20
Mild cervical dyskaryosis: safety of cytological surveillance. Lancet (1992) 3.09
Complacency in diagnosis of cervical cancer. Br Med J (Clin Res Ed) (1987) 3.07
Cellular and genetic control of antibody responses. V. Helper T-cell recognition of H-2 determinants on accessory cells but not B cells. J Exp Med (1979) 2.75
Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens. J Clin Microbiol (2001) 2.59
Genital wart virus infections: nuisance or potentially lethal? Br Med J (Clin Res Ed) (1984) 2.47
Cellular and genetic control of antibody responses in vitro. I. Cellular requirements for the generation of genetically controlled primary IgM responses to soluble antigens. Eur J Immunol (1977) 2.47
The social process of undocumented border crossing among Mexican migrants. Int Migr Rev (1998) 2.41
Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med (1981) 2.39
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer (1996) 2.30
Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol (1985) 2.28
Human Rad50 is physically associated with human Mre11: identification of a conserved multiprotein complex implicated in recombinational DNA repair. Mol Cell Biol (1996) 2.21
The abnormal cervical smear. Br Med J (Clin Res Ed) (1986) 2.19
Natural history of cervical epithelial abnormalities in patients with vulval warts. A colposcopic study. Br J Vener Dis (1983) 2.16
Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Mol Cell Probes (1997) 2.14
Inhibition of T-cell receptor beta-chain gene rearrangement by overexpression of the non-receptor protein tyrosine kinase p56lck. EMBO J (1992) 2.12
Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ (2000) 2.12
T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science (1993) 2.06
Non-invasive detection of cervical papillomavirus DNA. Lancet (1986) 2.05
Cellular and genetic control of antibody responses in vitro. IV. Expression of Ia antigens on accessory cells required for responses to soluble antigens including a response under Ir gene control. J Immunol (1978) 2.04
Cellular and genetic control of antibody responses in vitro. III. Immune response gene regulation of accessory cell function. J Exp Med (1978) 1.99
Urine osmolality in nursery school children in a hot climate. Isr J Med Sci (1993) 1.98
Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med (1994) 1.97
What is the optimum treatment of cervical premalignancy? Br J Obstet Gynaecol (1982) 1.94
Role of confirmatory PCRs in determining performance of Chlamydia Amplicor PCR with endocervical specimens from women with a low prevalence of infection. J Clin Microbiol (1994) 1.94
Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis (1996) 1.91
Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol (1988) 1.90
Inhibition of T cell receptor expression and function in immature CD4+CD8+ cells by CD4. Science (1990) 1.89
Impact of introduction of colposcopy to a district general hospital. Br Med J (Clin Res Ed) (1984) 1.87
Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. J Immunol (1981) 1.85
Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity (2000) 1.83
Ability of commercial ligase chain reaction and PCR assays to diagnose Chlamydia trachomatis infections in men by testing first-void urine. J Clin Microbiol (1997) 1.81
Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata. Lancet (1985) 1.80
Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child (1989) 1.77
Women's involvement with the decision preceding their caesarean section and their degree of satisfaction. Br J Obstet Gynaecol (1996) 1.76
The use of cervicography in a primary screening service. Br J Obstet Gynaecol (1991) 1.76
Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage. J Immunol (1991) 1.75
Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J Exp Med (1990) 1.70
Histological and immunocytochemical study of cervical intraepithelial neoplasia (CIN) with associated HPV 6 and HPV 16 infections. J Clin Pathol (1986) 1.70
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun (2000) 1.70
Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med (1987) 1.67
Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet (1988) 1.66
Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly. Am J Hum Genet (2006) 1.66
Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells. J Clin Microbiol (2000) 1.63
Intrathymic signalling in immature CD4+CD8+ thymocytes results in tyrosine phosphorylation of the T-cell receptor zeta chain. Nature (1989) 1.62
The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice. J Immunol (1981) 1.60
Asymmetric signaling requirements for thymocyte commitment to the CD4+ versus CD8+ T cell lineages: a new perspective on thymic commitment and selection. Immunity (1995) 1.59
T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. J Immunol (1984) 1.59
Crosstalk in the mouse thymus. Immunol Today (1994) 1.59
Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med (1985) 1.57
Laparoscopic live donor nephrectomy with vaginal extraction: initial report. Am J Transplant (2010) 1.56
Disorganization and restoration of thymic medullary epithelial cells in T cell receptor-negative scid mice: evidence that receptor-bearing lymphocytes influence maturation of the thymic microenvironment. Eur J Immunol (1991) 1.53
The uterine cervix from adolescence to the menopause. Br J Obstet Gynaecol (1975) 1.53
T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4. Nature (1985) 1.53
Negative selection of precursor thymocytes before their differentiation into CD4+CD8+ cells. Science (1992) 1.53
Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol (1992) 1.53
Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol (1995) 1.50
Mechanisms of T cell-B cell interaction. Annu Rev Immunol (1983) 1.47
The narrow escape problem for diffusion in cellular microdomains. Proc Natl Acad Sci U S A (2007) 1.46
What role do bacteria play in persisting fistula formation in idiopathic and Crohn's anal fistula? Colorectal Dis (2015) 1.45
Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc Natl Acad Sci U S A (1996) 1.44
Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Vaccine (2010) 1.42
Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens. J Exp Med (1983) 1.42
Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC. Nature (1986) 1.41
Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation (2001) 1.40
Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr (2014) 1.40
The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood (2001) 1.39
Use of refractometers to detect controlled-substance tampering. Am J Hosp Pharm (1991) 1.39
Cytological status and lesion size: a further dimension in cervical intraepithelial neoplasia. Br J Obstet Gynaecol (1989) 1.38
Can physics and physical chemistry explain the workings of homeopathy? A clinician's view. J Altern Complement Med (1998) 1.38
Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses. J Immunol (1984) 1.37
Specific nature of hydrolysis of insulin and tobacco mosaic virus protein by thermolysin. Arch Biochem Biophys (1966) 1.37
Post-transcriptional regulation of early T cell development by T cell receptor signals. Science (1992) 1.37
The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res (1997) 1.37
The soft x-ray instrument for materials studies at the linac coherent light source x-ray free-electron laser. Rev Sci Instrum (2012) 1.36
Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells. J Exp Med (1983) 1.35
Observations on the specificity of a thermostable bacterial protease "thermolysin". Biochem Biophys Res Commun (1965) 1.35
Role of accessory cells in B cell activation. I. Macrophage presentation of TNP-Ficoll: evidence for macrophage-B cell interaction. J Immunol (1980) 1.34
Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol (1999) 1.31
Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. J Exp Med (1986) 1.29
Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation. J Immunol (1980) 1.29
Stoichiometry of the T cell antigen receptor (TCR) complex: each TCR/CD3 complex contains one TCR alpha, one TCR beta, and two CD3 epsilon chains. J Exp Med (1994) 1.28
Human papillomavirus types 6 and 16 in multifocal intraepithelial neoplasias of the female lower genital tract. Br J Obstet Gynaecol (1985) 1.27
Self recognition in allogeneic thymic chimeras. Self recognition by T helper cells from thymus-engrafted nude mice is restricted to the thymic H-2 haplotype. J Exp Med (1982) 1.27
Engagement of the CD4 molecule influences cell surface expression of the T-cell receptor on thymocytes. Nature (1988) 1.26
Coherence properties of individual femtosecond pulses of an x-ray free-electron laser. Phys Rev Lett (2011) 1.26
Characterization of antigen-specific, Ia-restricted, L3T4+ cytolytic T lymphocytes and assessment of thymic influence on their self specificity. J Exp Med (1985) 1.26
Odortypes: their origin and composition. Proc Natl Acad Sci U S A (1999) 1.26
Distinct B cell subpopulations differ in their genetic requirements for activation by T helper cells. Immunol Rev (1982) 1.26